Search

everythinglearnresearchcommunity

for

Search:↓

The new Brigatinib nanocarrier is more effective against lung cancer cells than the free drug.

Upadacitinib may effectively treat both alopecia universalis and Crohn's disease.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Tofacitinib helped most teenagers in the study regrow hair with mild side effects.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Patients with alopecia areata prefer treatments that regrow scalp hair quickly over how often they need to take the medication.

Tofacitinib might be used to treat hair loss.

Oral betamethasone works faster than oral tofacitinib for hair regrowth in alopecia areata.

Caribine from traditional Chinese medicine may help treat hair loss.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Tofacitinib can cause skin eruptions similar to palmoplantar pustulosis.

Selumetinib causes fewer and less severe skin issues in children than binimetinib.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

A new compound shows promise as a topical treatment for hair loss.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Tenofovir alafenamide fumarate is effective and safer for hepatitis B, with fewer side effects than tenofovir disoproxil fumarate.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

The combination treatment showed a higher response rate but no significant survival benefits.

Cinacalcet may help treat hereditary vitamin D resistant rickets safely.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

New treatments targeting the JAK signaling pathway, especially JAK inhibitors, show promise for alopecia areata.

Tofacitinib helped a person with total body hair loss grow hair again without bad side effects.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.